Info
Significant Ownership

Significant Ownership of Orca Capital AG

Signature - Title: /s/ Thomas Konig - Thomas Konig/Director
Location: Pfaffenhofen, Germany
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Orca Capital AG.

Follow Filing Activity

Follow Orca Capital AG and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Useful next steps after a schedule filing

Use the page below that answers the next obvious question about this reporting manager or security.

Latest 13D/G reports to compare this manager with other current ownership disclosures.
Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
Latest 13F portfolio filings for broader institutional context.
Latest investment quarter holder pages when the next step is security-level holder history.

Significant Ownership of Orca Capital AG

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SLXN	Silexion Therapeutics Corp	Ordinary Shares, par value $0.0135 per share	4.9%	$802,137		109,432		Orca Capital AG	11 Sep 2025
PHIO	Phio Pharmaceuticals Corp.	Common Stock, par value $0.0001 per share	4.9%	$770,351	-$231,251	538,707	-23%	Orca Capital AG	08 Dec 2025
PPBT	Purple Biotech Ltd.	American Depositary Shares, each representing 200 Ordinary Shares	4.9%	$652,619		306,394		Orca Capital AG	04 Sep 2025
KTTA	Pasithea Therapeutics Corp.	Common Stock, par value $0.0001 per share	4.9%	$613,228	-$14,002	362,857	-2.2%	Orca Capital AG	07 May 2025
SXTP	60 Degrees Pharmaceuticals, Inc.	Common Stock, par value $0.0001 per share	4.9%	$382,327		166,229		Orca Capital AG	15 Jul 2025
VERO	Venus Concept Inc.	Common Stock, par value $0.001 per share	4.9%	$253,353	+$253,353	101,748		Orca Capital AG	06 Jun 2025
ENVB	Enveric Biosciences, Inc.	Common Stock, par value $0.01 per share	4.9%	$32,016	-$22,984	97,019	-42%	Orca Capital AG	31 Jan 2025
ATON	AlphaTON Capital Corp	Ordinary Shares, no par value	4.5%	$400,000	-$481,250	640,000	-55%	Orca Capital AG	28 Jan 2026
LIXT	Lixte Biotechnology Holdings, Inc.	Common Stock, par value $0.0001 per share	4.5%	$157,216	-$127,568	120,012	-45%	Orca Capital AG	14 Feb 2025
RANI	Rani Therapeutics Holdings, Inc.	Class A Common Stock, par value $0.0001 per share	4.3%	$972,105	-$1,265,416	1,891,623	-57%	Orca Capital AG	22 Jul 2025
CANF	Can-Fite BioPharma Ltd.	Ordinary Shares, no par value	4.1%	$188,859,240	-$261,140,760	157,382,700	-58%	Orca Capital AG	22 Apr 2025
CODX	Co-Diagnostics, Inc.	Common Stock, par value $0.001 per share	3.7%	$818,338	+$19,827	2,248,182	+2.5%	Orca Capital AG	28 Oct 2025
DWTX	Dogwood Therapeutics, Inc.	Common Stock, par value $0.0001 per share	3.7%	$390,299	-$256,967	69,821	-40%	Orca Capital AG	14 Mar 2025
SPCB	SuperCom Ltd.	Ordinary Shares, par value NIS 50	3.6%	$749,990	-$891,827	124,583	-54%	Orca Capital AG	31 Jan 2025
DCX	Digital Currency X Technology Inc.	Ordinary Shares, par value US$0.3	0.6%	$121,139	-$316,146	121,139	-72%	Orca Capital AG	31 Dec 2025
HCTI	Healthcare Triangle, Inc.	Common Stock, par value $0.00001 per share	0.2%	$14,699	-$607,501	2,033	-98%	Orca Capital AG	04 Mar 2026
SGLY	Singularity Future Technology Ltd.	Common Stock, no par value	0%	$0	-$191,334	0	-100%	Orca Capital AG	31 Jan 2025
SGN	Signing Day Sports, Inc.	Common Stock, par value $0.0001 per share	0%	$0	-$1,522,460	0	-100%	Orca Capital AG	20 Jan 2026
BHAT	Blue Hat Interactive Entertainment Technology	Ordinary Shares, par value $0.01 per share	0%	$0	-$248,400	0	-100%	Orca Capital AG	13 Jan 2025

Schedules 13D/G Reported by Orca Capital AG:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.